We exemplify this technology in the context of citrullinated Tenascin C and demonstrate shared features between cit-TNC-specific T cells from different HLA-DRB1*04:01-positive RA patients and between PB and SF. The gene discussed is HLA-DRB1; the disease is rheumatoid arthritis.